{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-009042","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2024-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.939617+00:00","generated_at":"2026-06-05T02:27:07.039983+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Palisade Bio director Mary Ann Gray resigns; board adopts declassified structure","bullets":["Director Mary Ann Gray resigned effective March 4, 2024, with no disagreement with company.","Board adopted amended bylaws removing classified board structure; directors will now be elected annually.","Change to annual director elections takes effect at the 2024 annual meeting of shareholders.","Other minor administrative amendments were also made to the bylaws."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-009042","json":"https://secwatch.observer/filing/0001493152-24-009042.json","markdown":"https://secwatch.observer/filing/0001493152-24-009042.md","text":"https://secwatch.observer/filing/0001493152-24-009042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224009042/0001493152-24-009042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224009042/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T02:27:07.039983+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d656c854cf","claim":"Mary Ann Gray resigned as Director at PALISADE BIO, INC..","evidence_excerpt":"On March 4, 2024, Mary Ann Gray, Ph.D. informed the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) that she is resigning as a member of the Board effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224009042/0001493152-24-009042-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"95d268e3ac9705b8cf9e9f41c8a6264c46d926f2","claim":"PALISADE BIO, INC.: Amended and restated bylaws to remove classified board structure and provide for annual election of all directors, effective at 2024 annual meeting (effective 2024-02-29).","evidence_excerpt":"On February 29, 2024, the Board adopted amended and restated bylaws (the “Amended and Restated Bylaws”) for the purpose of removing the Company’s classified Board structure and to provide for the annual election of all members of the Board.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224009042/0001493152-24-009042-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2024-02-29"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}